This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Insiders Love Right Now

Opko Health

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Key insiders have been doing some big buying in Opko Health (OPK - Get Report), a pharmaceutical and diagnostics company. It is focused on developing a range of solutions, including molecular diagnostics tests, pharmaceuticals and vaccines. This stock has done nothing so far in 2012 since shares are virtually flat on the year.

Opko Health has a market cap of $1.39 billion and an enterprise value of $1.31 billion. This stock trades at a premium valuation, with a price-to-sales of 32.27 and a price-to-book of 13.51. Its estimated growth rate for this year is -50%, and for next year it's pegged at -16.7%. This is a cash-rich company, since the total cash position on its balance sheet is $87.42 million and its total debt is $12.55 million.

The CEO and chairman of the board just bought 620,000 shares, or $3.08 million worth of stock, at $4.78 to $5.07 per share. This same CEO also bought over $2.5 million worth of stock in February.

From a technical perspective, OPK is currently trading above its 200-day moving average and below its 50-day moving average, which is neutral trendwise. This stock has consistently found buying interest over the last six months whenever it has traded down towards $4.65 to $4.80 a share.

If you're bullish on OPK, I would look for long biased trades as long as $4.65 and its 200-day moving average of $4.59 hold up as support levels. If you get a chance to buy near those levels, I would then add to any long positions off on any high-volume strength back above its near-term overhead resistance at $5.08 to $5.53 a share. Look for volume on a move over those levels that are near or well above its three-month average of 1.6 million shares.

Opko, one of Jana Partners' holdings, was also featured recently in " 12 Bargain Stocks With Insider Support."

2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
MKTG $0.00 0.00%
GNE $7.22 0.00%
APC $51.95 0.00%
OPK $10.46 0.00%
WPRT $2.60 0.00%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs